Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

12:40 PM - 12:50 PM ET

274 - Osimertinib Combined with Stereotactic Body Radiotherapy vs. Osimertinib Alone in Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase II Randomized Controlled Trial
Speaker: Zheng, Xiaoli, MD - The affiliated cancer hospital of Zhengzhou University, Zhengzhou, Henan
12:45 PM - 12:50 PM ET

1111 - Building a Scalable Radiation Oncology Access Database: Lessons from a Geospatial Analysis of Oregon
Speaker: Butler, John, MD, PhD - University of California San Diego, San Diego, CA
12:45 PM - 12:50 PM ET

1117 - Improving Radiation Oncology Nursing Competence through a Structured, Needs-Based Education Initiative
Speaker: Gay, Kailey, BSN - Moffitt Cancer Center, Tampa, FL
12:48 PM - 12:57 PM ET

257 - Comparison of Xerostomia in Head and Neck Cancer Patients Undergoing Radiation with and without Parotid Duct Sparing via MRI Sialography: A Randomised Control Study
Speaker: Singh, Pritanjali, MBBS, DNB - All India Institute of Medical Sciences Patna, Patna, Bihar
12:50 PM - 12:55 PM ET

1112 - National Job Satisfaction, Workforce Stability, and Transition Patterns among U.S. Radiation Oncologists: A Comprehensive ASTRO Early Career and Workforce Committee Survey
Speaker: Sim, Austin, MD, JD - The Ohio State University Comprehensive Cancer Center, Columbus, OH
12:50 PM - 12:55 PM ET

1118 - The Role of Multidimensional Individualized Clinical Management in Radiotherapy for Patients with Head and Neck Cancer: A Prospective Observational Study
Speaker: Wang, Ting - Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi
12:50 PM - 1:00 PM ET

239 - Newly Adult Malignant Brainstem Glioma Treated with Anlotinib Plus Radiotherapy: A Multicenter, Phase II Study
Speaker: Chen, Yuanyuan, MD - Sun Yat-Sen University Cancer Center, Guang Dong Province, Guangdong
12:50 PM - 1:00 PM ET

245 - Blood Dose Based NTCP Modeling for Severe Radiation Induced Lymphopenia In Lung Cancer Radiotherapy
Speaker: Dai, Tianyuan, PhD - Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
12:50 PM - 1:00 PM ET

251 - PSMA-PET/CT-Guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT) : Five-Year Primary Endpoint of a Phase 2 Randomized Controlled Trial
Speaker: Belliveau, Colin, MD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, QC
12:50 PM - 1:00 PM ET

262 - K48-Linked SUMOylation of UBC9 Drives Tumor Radioresistance by Suppressing MHC-I Antigen Presentation
Speaker: Xing, Xiaoke - Shandong Cancer Hospital and Institute, Jinan, shandong
12:50 PM - 1:00 PM ET

268 - Simultaneous Anatomical Deformation Reconstruction and Tumor Motion Tracking Guided by Multimodal Respiratory Surrogates: Framework Development and Multi-Center Validation
Speaker: Zhang, Gongsen, MD - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, Shandong
12:50 PM - 1:00 PM ET

275 - FLT3 Ligand (CDX-301) and Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer
Speaker: Ohri, Nitin, MD, MS - Albert Einstein College of Medicine, Bronx, NY